CAS 70024-40-7
:Terazosin monohydrochloride dihydrate
Description:
Terazosin monohydrochloride dihydrate is a pharmaceutical compound primarily used as an antihypertensive and for the treatment of benign prostatic hyperplasia (BPH). It belongs to the class of alpha-1 adrenergic antagonists, which work by relaxing blood vessels and improving urine flow. The substance appears as a white to off-white crystalline powder and is soluble in water, making it suitable for oral administration. Its chemical structure includes a piperazine ring, contributing to its pharmacological activity. The dihydrate form indicates that the compound contains two molecules of water, which can influence its stability and solubility characteristics. Terazosin is typically administered in tablet form, and its dosage may vary based on the condition being treated. Common side effects may include dizziness, fatigue, and hypotension, particularly upon initiation of therapy. As with any medication, it is essential to use terazosin under medical supervision to monitor for potential interactions and side effects.
Formula:C19H30ClN5O6
InChI:InChI=1/C19H25N5O4.ClH.2H2O/c1-26-15-10-12-13(11-16(15)27-2)21-19(22-17(12)20)24-7-5-23(6-8-24)18(25)14-4-3-9-28-14;;;/h10-11,14H,3-9H2,1-2H3,(H2,20,21,22);1H;2*1H2
InChI key:InChIKey=NZMOFYDMGFQZLS-UHFFFAOYSA-N
SMILES:NC=1C2=C(N=C(N1)N3CCN(C(=O)C4CCCO4)CC3)C=C(OC)C(OC)=C2.Cl.O
Synonyms:- 1-(4-Amino-6,7-Dimethoxy-2-Quinazolinyl)-4-((Tetrahydro-2- Furanyl)Carbonyl)-
- 1-(4-Amino-6,7-Dimethoxy-2-Quinazolinyl)-4-(Tetrahydro-2-Furanyl-)Carbonyl)-Piperazine Hydrochloride Dihydrate
- 1-(4-Amino-6,7-dimethoxy-2-quinazolinyl)-4-(tetrahydro-2-furoyl)pipera zine
- Methanone, [4-(4-amino-6,7-dimethoxy-2-quinazolinyl)-1-piperazinyl](tetrahydro-2-furanyl)-, hydrochloride, hydrate (1:1:2)
- Piperazine, 1-(4-amino-6,7-dimethoxy-2-quinazolinyl)-4-[(tetrahydro-2-furanyl)carbonyl]-, monohydrochloride, dihydrate
- Prestwick0_000751
- Prestwick1_000751
- SPBio_002701
- Smr000058309
- Terazosin HCl
- Terazosin Hydrochloride Dihydrate
- Terazosin monohydrochloride dihydrate
- [4-(4-Amino-6,7-Dimethoxy-Quinazolin-2-Yl)Piperazin-1-Yl]-(Oxolan-2-Yl)Methanone
- [4-(4-Amino-6,7-Dimethoxyquinazolin-2-Yl)Piperazin-1-Yl](Tetrahydrofuran-2-Yl)Methanone Hydrochloride Dihydrate
- iperazinehcl2h2o
- TerazosinHclC19H26C1N504
- TERAZOSIN HCL 2H2O
- Terazosin HCL dihydrate
- Hytrinex
- See more synonyms
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Found 14 products.
Terazosin Hydrochloride Dihydrate
CAS:Formula:C19H25N5O4·HCl·2H2OPurity:>98.0%(HPLC)(N)Color and Shape:White to Almost white powder to crystalMolecular weight:459.93TERAZOSIN HYDROCHLORIDE DIHYDRATE CRS
CAS:<p>TERAZOSIN HYDROCHLORIDE DIHYDRATE CRS</p>Formula:C19H30ClN5O6Color and Shape:Crystalline Powder. White. Light Yellow. Powder.Molecular weight:459.9244Terazosin Hydrochloride
CAS:<p>Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoi</p>Formula:C19H25N5O4·HClColor and Shape:White Light Yellow PowderMolecular weight:423.16733Terazosin hydrochloride dihydrate
CAS:Formula:C19H30ClN5O6Purity:98%Color and Shape:SolidMolecular weight:459.9244Terazosin hydrochloride dihydrate
CAS:<p>Terazosin hydrochloride dihydrate</p>Purity:≥98%Molecular weight:459.92g/mol1-(4-Amino-6,7-Dimethoxy-2-Quinazolinyl)-4-[(Tetrahydro-2-Furanyl)Carbonyl]Piperazine Hydrochloride
CAS:<p>1-(4-Amino-6,7-Dimethoxy-2-Quinazolinyl)-4-[(Tetrahydro-2-Furanyl)Carbonyl]Piperazine Hydrochloride</p>Purity:98%Molecular weight:423.89g/molTerazosin hydrochloride dihydrate
CAS:<p>Terazosin hydrochloride dihydrate (Heitrin dihydrate) is a selective α1-adrenoceptor antagonist, used for treatment of symptoms of an enlarged prostate (BPH).</p>Formula:C19H25N5O4·HCl·2H2OPurity:99.81%Color and Shape:White Or Off-White Crystalline PowderMolecular weight:459.92Terazosin Hydrochloride Dihydrate
CAS:Controlled ProductFormula:C19H25N5O4·ClH·2H2OColor and Shape:NeatMolecular weight:459.92Terazosin hydrochloride dihydrate
CAS:<p>α1-adrenergic receptor antagonist; activator of Pgk1 and HSP90</p>Formula:C19H25N5O4•HCl•(H2O)2Purity:Min. 95%Color and Shape:White PowderMolecular weight:459.92 g/molTerazosin HCl dihydrate - Bio-X ™
CAS:<p>As an inhibitor of alpha-1 adrenergic receptors, Terazosin causes vasodilation followed by a reduction in urethral resistance, venous return to the heart and peripheral vascular resistance. In particular Terazosin's ability to recover urine flow and alleviate symptoms in patients with benign prostatic hyperplasia is of benefit to the therapeutic and clinical industries.</p>Formula:C19H25N5O4·ClH·2H2OPurity:(%) Min. 95%Color and Shape:PowderMolecular weight:459.92 g/mol6,7-dimethoxy-2-[4-(oxolane-2-carbonyl)piperazin-1-yl]quinazolin-4-amine hydrochloride
CAS:Formula:C19H26ClN5O4Purity:≥98%(HPLC)Molecular weight:423.9












